Nordic Journal of Psychiatry
September 29, 2022
Tobias Søgaard Juul, Mathias E. Jensen, Anders Fink‐jensen
20 citations
Among Danish adults, classic psychedelics were primarily used for therapeutic or spiritual purposes and were linked to self-reported positive lasting effects, though they were also associated with hazardous alcohol use. DMT was linked to significantly greater positive effects than LSD and psilocybin.
Nordic Journal of Psychiatry
July 5, 2017
Jens Knud Larsen
15 citations
A retrospective database study of mental health patients who used LSD or psilocybin found that these drugs may be associated with serious short- and long-term side effects. The authors caution that until rigorous trials clarify the potential harms, the clinical utility of these substances in mental health patients remains unclear.
Nordic Journal of Psychiatry
July 20, 2017
David Erritzoe, William A. Richards
14 citations
Psychedelic therapies are being re-evaluated for treating conditions like major depression, cancer-related anxiety and depression, and alcohol use disorder. The research examines their effects and safety, suggesting potential benefits for these psychopathologies.
Nordic Journal of Psychiatry
January 1, 1996
Jørgen Due Madsen, Asle Hoffart
7 citations
Between 1961 and 1976, Modum Bads Nervesanatorium in Norway treated 379 inpatients with hallucinogens—LSD, psilocybin, and CZ 74—in a procedure called psycholytic treatment. Patients received 2,205 treatments, mostly with LSD. Forty percent were women, 60% men. Diagnoses included psychoses (4.5%), obsessive neurosis (11.1%), other psychoneuroses (26.3%), sexual deviation (6.3%), other character disorders (46.2%), alcoholism (5.0%), and drug addiction (0.5%). Obsessive neurosis was the primary diagnosis in 1961 (35.7%) and again in the last seven years (75.6%). The mean hospitalization for treated patients was 132 days, nearly double the hospital average of 68 days.
Nordic Journal of Psychiatry
July 10, 2025
Pernille Kølbæk, Søren Dinesen Østergaard, Jens Larsen
Future clinical studies of psychedelic treatment for mental disorders should account for the high incidence of flashbacks. The text highlights that flashbacks occur frequently and must be considered in research design, though it does not specify the exact rate or population studied.